Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $1.7 billion.

  • Novartis Ag's Cash from Financing Activities rose 15617.49% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$14.9 billion, marking a year-over-year decrease of 2661.39%. This contributed to the annual value of -$14.9 billion for FY2025, which is 2661.39% down from last year.
  • As of Q4 2025, Novartis Ag's Cash from Financing Activities stood at $1.7 billion, which was up 15617.49% from -$2.8 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Cash from Financing Activities registered a high of $1.7 billion during Q4 2025, and its lowest value of -$9.5 billion during Q1 2022.
  • In the last 5 years, Novartis Ag's Cash from Financing Activities had a median value of -$3.5 billion in 2021 and averaged -$4.1 billion.
  • In the last 5 years, Novartis Ag's Cash from Financing Activities crashed by 93128.65% in 2021 and then surged by 15617.49% in 2025.
  • Quarter analysis of 5 years shows Novartis Ag's Cash from Financing Activities stood at -$3.3 billion in 2021, then fell by 26.08% to -$4.1 billion in 2022, then surged by 87.9% to -$496.0 million in 2023, then tumbled by 504.03% to -$3.0 billion in 2024, then soared by 156.17% to $1.7 billion in 2025.
  • Its Cash from Financing Activities stands at $1.7 billion for Q4 2025, versus -$2.8 billion for Q3 2025 and -$5.2 billion for Q2 2025.